S2Medical AB (publ)
STO: S2M.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Petter Sivler
- Employees
- 17
- Headquarters
- Linköping, Sweden
- IPO year
- 2018
- Market cap
- SEK 5.7M
- Website
- https://www.s2m.se
Loading S2M…
Loading profile data…Frequently asked questions about S2M
What does S2Medical AB (publ) (S2M.ST) do?
S2Medical AB (publ) develops, produces, and sells wound healing products for burns and chronic wounds. It offers INSTAQRETT, a sterile single use mechanical debridement tool; EPIPROTECT SafeStop for blood stilling; Instagraft, a single-use medical device for the treatment of chronic and complicated wounds; EPIPROTECT tissue substitutes; and wash...
Where does S2M.ST trade?
S2Medical AB (publ) (S2M.ST) trades on the Stockholm Stock Exchange.
What sector is S2M.ST in?
S2Medical AB (publ) (S2M.ST) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of S2Medical AB (publ)?
Petter Sivler is the chief executive officer of S2Medical AB (publ) (S2M.ST).
Where is S2Medical AB (publ) headquartered?
S2Medical AB (publ) is headquartered in Sweden.
Does S2M.ST pay a dividend?
S2Medical AB (publ) (S2M.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did S2M.ST go public?
S2Medical AB (publ) (S2M.ST) completed its initial public offering in 2018.